ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Press
August 6, 2024
22 Nov 2022

Acarix resolves on a partially guaranteed rights issue of approximately SEK 52.9 million

THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, A...
Continue reading
author-avatar acarix
Press
August 6, 2024
22 Nov 2022

Acarix beslutar om partiellt garanterad företrädesemission om cirka 52,9 MSEK

DETTA PRESSMEDDELANDE ÄR EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING, VARKEN DIREKT ELLER INDIREKT, INOM ELLER TILL USA, AU...
Continue reading
author-avatar acarix
Press
August 6, 2024
16 Nov 2022

Full focus on the US market with strong interest from healthcare providers, reimbursement code in place and collaboration with ACC

Acarix is now taking an important strategic step, putting full commercial focus on the US market. We have the key building blocks in pl...
Continue reading
author-avatar acarix
Press
August 6, 2024
16 Nov 2022

Fullt fokus på USA med stort intresse från sjukvården, egen reimbursementkod på plats och samarbete med ACC

Acarix tar nu ett viktigt strategiskt kliv och lägger fullt kommersiellt fokus på USA-marknaden. Vi har de viktiga byggstenarna på plat...
Continue reading
author-avatar acarix
Press
August 6, 2024
26 Sep 2022

Acarix and the American College of Cardiology announce strategic collaboration

The American College of Cardiology (“ACC”) and Acarix have signed a strategic collaboration agreement with the goal to develop a clinic...
Continue reading
author-avatar acarix
Press
August 6, 2024
26 Sep 2022

Acarix och American College of Cardiology tecknar strategiskt samarbete

American College of Cardiology (“ACC”) och Acarix har tecknat ett strategiskt samarbetsavtal med syfte att utveckla ett kliniskt progra...
Continue reading
author-avatar acarix
Press
August 6, 2024
25 Aug 2022

Acarix AB (publ) publishes Interim Report, January – June 2022

Significant interest and positive developments in the US market We can now conclude that our Go-To-Market strategy in the USA has start...
Continue reading
author-avatar acarix
Press
August 6, 2024
25 Aug 2022

Acarix AB (publ) publicerar delårsrapport, januari – juni 2022

Stort intresse och positiv utveckling på den amerikanska marknaden Vi kan nu konstatera att vår Go-To-Market strategi i USA börjat gene...
Continue reading
author-avatar acarix
Press
August 6, 2024
22 Jun 2022

Acarix tecknar samarbetsavtal med Strategic Health AK för att införa CADScor®System i Alaska

Pressmeddelande Malmö, 22 juni, 2022  Acarix tecknar samarbetsavtal med Strategic Health AK för att införa CADScor®System i Alaska A...
Continue reading
author-avatar acarix
Press
August 6, 2024
22 Jun 2022

Acarix partners with Strategic Health AK to roll-out CADScor®System across the state of Alaska

Press release Malmö, Sweden, June 22, 2022   Acarix partners with Strategic Health AK to roll-out CADScor®System across the state of A...
Continue reading
author-avatar acarix
Press
August 6, 2024
11 May 2022

Acarix AB (publ) publicerar delårsrapport, januari – mars 2022

Pressmeddelande Malmö, 11 maj 2022   Acarix AB (publ) publicerar delårsrapport, januari - mars 2022 Ökat momentum i verksamheten och ...
Continue reading
author-avatar acarix
Press
August 6, 2024
11 May 2022

Acarix AB (publ) publishes Interim Report, January – March 2022

Press release Malmö, Sweden, May 11, 2022   Acarix AB (publ) publishes Interim Report, January – March 2022 Increased commercial mome...
Continue reading
  • «
  • ‹
  • 6
  • 7
  • 8
  • 9
  • 10
  • ›
  • »
Acarix AB
Jungmansgatan 12
211 19 Malmö
SE
[email protected]

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V5

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.